Erin Mistry

Erin Mistry is a global leader in biotech/pharma pricing and market access, boasting over 15 years of experience in developing and leading teams in global pricing, market access, and portfolio strategies across various markets. Erin excels at utilizing robust analytics to drive insights and recommendations.

With a unique skill set, Erin has directly worked with clinical providers, CMS, and patient engagement organizations to bridge the gap during the development and communication of value messaging to access stakeholders like KOLs, payers, and integrated delivery networks.

Erin has demonstrated exceptional leadership and business building capabilities in high-profile biotechnology and pharmaceutical organizations, covering a wide range of therapeutic categories. Erin's specialties include global pricing & market access, strategy creation, segmentation & profiling, private & public valuations, market research, brand creation, financial modeling, business planning, business development, relationship management, organization design & creation, key messaging, leadership, general management, and commercialization.

Erin's educational background includes a Master of Science in Biomechanics from North Carolina State University, Executive and Continuing Professional Education from Harvard T.H. Chan School of Public Health, and a Bachelor of Science in Industrial Engineering, also from North Carolina State University.

Throughout Erin's career, they have been involved with various prestigious organizations, including serving as a Board of Directors member at Antimicrobials Working Group, Chief Founding Member at Chief, Senior Vice President at Cormedix Inc., MassCONNECT Mentor at MassBio, and holding leadership positions at companies like Intarcia Therapeutics, Inc., Syneos Health, Jupiter Life Science Consulting, Patient Engagement Advisors, MedImmune, and Duke University Health System.